NCT05020145
- Conditions
- Breakthrough Infection, Breakthrough Infections, COVID-19, +18 more
- Locations
-
- Pfizer Inc. New York, United States
Clinical trial condition
Immunosuppressed
Explore clinical trials studying Immunosuppressed. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Immunosuppressed trial results
NCT01022931
- Conditions
- Asthma, Asthmatic, Bronchial Diseases, +15 more
- Locations
-
- Children's Hospital of Geneva, HUG Geneva, Canton of Geneva, Switzerland